HIV Prevention Drug Cleared to Drop Some Warnings From Packaging

Makers of HIV prevention medication will no longer need to include some materials that warn users and health-care professionals about the drug’s risks, the Food and Drug Administration said July 1.

Prescribers and users of Truvada, the only HIV prevention medication on the market, are now more familiar with its risks, so the FDA eliminated the requirement that the educational materials be included with the product.

The warning, known as a risk evaluation and mitigation strategy, was also designed to educate users about other prevention methods they should follow.

Truvada was first approved as a method of HIV prevention, or ...